ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
$7.30 -0.21 (-2.80%)
As of 05/24/2022 12:45:27 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.